Slowing diabetes progression, artificial sweeteners and type 2 diabetes risk, and more!

09/05/23 • 53 min

Announcement of an upcoming special episode of Diabetes Care “On Air” on diabetes and social determinants of health, Sandra C. Naamann and George L. Bakris on the pillars of therapy for slowing diabetes progression, Mathilde Touvier on artificial sweeteners and type 2 diabetes risk, and more!

Welcome to episode no. 10 (September 2023) of Diabetes Care “On Air”—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the September 2023 issue of Diabetes Care.

0:43: Alice announces a special episode of Diabetes Care “On Air,” to be released later in the month. This special episode will focus on this year’s Diabetes Care Symposium on the impact of social determinants of health for diabetes development and care. The episode will feature a panel discussion with the authors of the articles presented at the symposium.

1:15: Mike interviews Sandra C. Naaman and George L. Bakris, authors of “Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression.” This study is an editor-selected feature article appearing in the September 2023 issue and is openly accessible at https://doi.org/10.2337/dci23-0030.

30:30: Alice interviews Mathilde Touvier, senior author of “Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort.” This study is also an editor-selected feature article appearing in the September 2023 issue and is openly accessible at https://doi.org/10.2337/dc23-0206.

41:30: In the “Diabetes Care Rapid Exchange,” Alice and Mike wrap up the episode by reviewing several interesting articles in the September 2023 issue of Diabetes Care. Studies highlighted in this segment include:

Rafael Simó et al. Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-World Population-Based Study in Subjects With Type 2 Diabetes. https://doi.org/10.2337/dc22-2521
Jose Garcia-Tirado et al. Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes. https://doi.org/10.2337/dc23-0119
Oliver Artz et al. Grading Fractures on Foot and Ankle X-rays and MRI Scans in the Active Charcot Foot in Diabetes: How Strong Is the Agreement Between Modalities? https://doi.org/10.2337/dc23-0220
Yaogan Luo et al. Diet-Related Lipidomic Signatures and Changed Type 2 Diabetes Risk in a Randomized Controlled Feeding Study With Mediterranean Diet and Traditional Chinese or Transitional Diets. https://doi.org/10.2337/dc23-0314
Rodolfo J. Galindo et al. A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c 39–15%: DUAL HIGH Trial. https://doi.org/10.2337/dc22-2426
Andrea Kalus et al. Evaluation of Insulin Pump Infusion Sites in Type 1 Diabetes: The DERMIS Study. https://doi.org/10.2337/dc23-0426

To learn more about Diabetes Care, please visit diabetesjournals.org/care. Interested in submitting cover art to the journal? Please visit https://diabetesjournals.org/care/pages/submit_a_cover_image.

Rafael Simó et al. Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-World Population-Based Study in Subjects With Type 2 Diabetes. https://doi.org/10.2337/dc22-2521
Jose Garcia-Tirado et al. Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes. https://doi.org/10.2337/dc23-0119
Oliver Artz et al. Grading Fractures on Foot and Ankle X-rays and MRI Scans in the Active Charcot Foot in Diabetes: How Strong Is the Agreement Between Modalities? https://doi.org/10.2337/dc23-0220
Yaogan Luo et al. Diet-Related Lipidomic Signatures and Changed Type 2 Diabetes Risk in a Randomized Controlled Feeding Study With Mediterranean Diet and Traditional Chinese or Transitional Diets. https://doi.org/10.2337/dc23-0314
Rodolfo J. Galindo et al. A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c 39–15%: DUAL HIGH Trial. https://doi.org/10.2337/dc22-2426
Andrea Kalus et al. Evaluation of Insulin Pump Infusion Sites in Type 1 Diabetes: The DERMIS Study. https://doi.org/10.2337/dc23-0426

Previous Episode

undefined - Taking stock of Diabetes Care “On Air” so far, technology in the care of older adults with diabetes, metformin and the risk of congenital malformations in pregnant individuals with type 2 diabetes, and more

Taking stock of Diabetes Care “On Air” so far, technology in the care of older adults with diabetes, metformin and the risk of congenital malformations in pregnant individuals with type 2 diabetes, and more

Welcome to episode no. 9 (August 2023) of Diabetes Care “On Air”—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the August 2023 issue of Diabetes Care.

0:52: Before launching into this month’s feature interviews, Alice and Mike recap their first few months of working together on Diabetes Care “On Air.” Mike emphasizes how much he’s learned from the interviewees and from Alice, and he shares his hope that listeners also find the podcast enlightening. Alice has been impressed with how passionate the interviewers are about the diabetes research they are conducting. She also takes us behind the scenes to reveal that she performs her podcasting from her closet!

2:11: Mike interviews Elbert S. Huang, first author of “The Growing Role of Technology in the Care of Older Adults with Diabetes.” This study is an editor-selected feature article appearing in the August 2023 issue and is openly accessible at https://doi.org/10.2337/dci23-0021.

19:08: Alice interviews Lars J. Kjerpeseth, first author of “Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study.” This study is also an editor-selected feature article appearing in the August 2023 issue and is openly accessible at https://doi.org/10.2337/dc23-0256.

28:05: In the “Diabetes Care Rapid Exchange,” Alice and Mike wrap up the episode by reviewing several interesting articles in the August 2023 issue of Diabetes Care. Studies highlighted in this segment include:

Katharine J. McCarthy et al. Influence of Gestational Diabetes on Diabetes Risk and Glycemic Control in a Retrospective Population-Based Cohort. https://doi.org/10.2337/dc22-1676
Ruchi Sharan et al. The Association of Homelessness With Rates of Diabetes Complications: A Population-Based Cohort Study. https://doi.org/10.2337/dc23-0211
Fady T. Botros et al. Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis. https://doi.org/10.2337/dc23-0231
Hiddo J.L. Heerspink et al. Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis. https://doi.org/10.2337/dc23-0261
Aaron J. Deutsch et al. Type 2 Diabetes Polygenic Score Predicts the Risk of Glucocorticoid-Induced Hyperglycemia in Patients Without Diabetes. https://doi.org/10.2337/dc23-0353
Kristen J. Nadeau et al. Effect of Early Glycemic Control in Youth-Onset Type 2 Diabetes on Longer-Term Glycemic Control and β-Cell Function: Results From the TODAY Study. https://doi.org/10.2337/dc23-0560
Frederik Pagh Bredahl Kristensen et al. The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of β-Cell Function and Insulin Sensitivity. https://doi.org/10.2337/dc23-0079

Next Episode

Banting 100 years later, AI and retinopathy screening and diagnosis, stage 1 type 1 diabetes and islet autoimmunity, and more!

Remembering a critical breakthrough in diabetes research on a fateful night over 100 years ago, Anand E. Rajesh and Aaron Y. Lee on the incredible potential of artificial intelligence in screening for and diagnosing diabetic retinopathy, Brigitte I. Frohnert on stage 1 type 1 diabetes and multiple islet autoimmunity, and more!

Welcome to episode no. 11 (October 2023) of Diabetes Care “On Air”—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the October 2023 issue of Diabetes Care.

0:45: Alice kicks off the episode with a fun October fact about a critical breakthrough in diabetes research that occurred in 1920. This breakthrough came in the form of an idea in a dream of Sir Fredrick Banting in the early morning hours of Halloween that year, and this idea contributed greatly to the discovery and successful purification of insulin.

2:20: Alice interviews Anand E. Rajesh and Aaron Y. Lee, authors of “Artificial Intelligence and Diabetic Retinopathy: AI Framework, Prospective Studies, Head-to-head Validation, and Cost-effectiveness” This study is an editor-selected feature article appearing in the October 2023 issue and is openly accessible at https://doi.org/10.2337/dci23-0032.

22:54: Mike interviews Brigitte I. Frohnert, lead author of “Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity.” This study is also an editor-selected feature article appearing in the October 2023 issue and is openly accessible at https://doi.org/10.2337/dc22-1960.

43:36: In the “Diabetes Care Rapid Exchange,” Alice and Mike wrap up the episode by reviewing several interesting articles in the October 2023 issue of Diabetes Care. Studies highlighted in this segment include:

Sacks et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. https://doi.org/10.2337/dci23-0036
Speksnijder et al. Effect of Postmenopausal Hormone Therapy on Glucose Regulation in Women With Type 1 or Type 2 Diabetes: A Systematic Review and Meta-analysis. https://doi.org/10.2337/dc23-0451
Ahmed et al. Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes. https://doi.org/10.2337/dc23-0855
Wei et al. All-Cause Mortality and Cardiovascular and Microvascular Diseases in Latent Autoimmune Diabetes in Adults. https://doi.org/10.2337/dc23-0739
Osafehinti et al. Type 1 Diabetes Genetic Risk Score Differentiates Subgroups of Ketosis-Prone Diabetes. https://doi.org/10.2337/dc23-0622
Berg et al. A Skin Care Program to Prevent Skin Problems due to Diabetes Devices in Children and Adolescents: A Cluster-Controlled Intervention Study. https://doi.org/10.2337/dc23-0462